Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

Journal of Hepatology

Volumn 50, Issue 1, 2009, Pages 80-88

  Yuen, Man Fung ^a   Tanaka, Yasuhito ^b   Fong, Daniel Yee Tak ^a   Fung, James ^a   Wong, Danny Ka Ho ^a   Yuen, John Chi Hang ^a   But, David Yiu Kuen ^a   Chan, Annie On On ^a   Wong, Benjamin Chun Yu ^a   Mizokami, Masashi ^b   Lai, Ching Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Chronic hepatitis B; Hepatocellular carcinoma; Prediction; Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; VIRAL CORE PROTEINS; YOUNG ADULT;

EID: 56949094767     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.07.023     Document Type: Article

References (31)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med 337 (1997) 1733-1745
2. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2 (1981) 1129-1133
3. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25 (2005) 143-154
4. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang L.Y., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347 (2002) 168-174
5. Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Lu S.N., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73
6. Tsubota A., Arase Y., Ren F., Tanaka H., Ikeda K., and Kumada H. Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw. J Med Virol 65 (2001) 257-265
7. Chan H.L., Hui A.Y., Wong M.L., Tse A.M., Hung L.C., Wong V.W., et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53 (2004) 1494-1498
8. Tong M.J., Blatt L.M., Kao J.H., Cheng J.T., and Corey W.G. Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma. World J Gastroenterol 12 (2006) 6620-6626
9. Baptista M., Kramvis A., and Kew M.C. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29 (1999) 946-953
10. Kao J.H., Chen P.J., Lai M.Y., and Chen D.S. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124 (2003) 327-334
11. Liu C.J., Chen B.F., Chen P.J., Lai M.Y., Huang W.L., Kao J.H., et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis 193 (2006) 1258-1265
12. Yuen M.F., Yuan H.J., Wong D.K., Yuen J.C., Wong W.M., Chan A.O., et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 54 (2005) 1610-1614
13. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.S., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
14. Sugauchi F., Orito E., Ichida T., Kato H., Sakugawa H., Kakumu S., et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology 124 (2003) 925-932
15. Yuen M.F., Tanaka Y., Mizokami M., Yuen J.C., Wong D.K., Yuan H.J., et al. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis 25 (2004) 1593-1598
16. Heagerty P.J., Lumley T., and Pepe M.S. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56 (2000) 337-344
17. Hastie T., Tibshirani R., and Friedman J. The elements of statistical learning. 1st ed. (2001), Springer, New York p. 214-7
18. Yuen M.F., Tanaka Y., Shinkai N., Poon R.T., But D.Y., Fong D.Y., et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 57 (2008) 98-102
19. Yuen M.F., Sablon E., Yuan H.J., Wong D.K., Hui C.K., Wong B.C., et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology 37 (2003) 562-567
20. Sumi H., Yokosuka O., Seki N., Arai M., Imazeki F., Kurihara T., et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37 (2003) 19-26
21. Fujie H., Moriya K., Shintani Y., Yotsuyanagi H., Iino S., and Koike K. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Gastroenterology 120 (2001) 1564-1565
22. Sakugawa H., Nakasone H., Nakayoshi T., Orito E., Mizokami M., Yamashiro T., et al. Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan. J Med Virol 67 (2002) 484-489
23. Orito E., Mizokami M., Sakugawa H., Michitaka K., Ishikawa K., Ichida T., et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Hepatology 33 (2001) 218-223
24. Yuen M.F., Sablon E., Tanaka Y., Kato T., Mizokami M., Doutreloigne J., et al. Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol 41 (2004) 119-125
25. Liu C.J., Chen B.F., Chen P.J., Lai M.Y., Huang W.L., Kao J.H., et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. J Infect Dis 194 (2006) 594-599
26. Chou Y.C., Yu M.W., Wu C.F., Yang S.Y., Lin C.L., Liu C.J., et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 57 (2008) 91-97
27. Chauhan R., Kazim S.N., Bhattacharjee J., Sakhuja P., and Sarin S.K. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. J Med Virol 78 (2006) 1047-1054
28. Pang A., Yuen M.F., Yuan H.J., Lai C.L., and Kwong Y.L. Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis E antigen seroconversion. J Hepatol 40 (2004) 1008-1017
29. Lin C.L., Liu C.H., Chen W., Huang W.L., Chen P.J., Lai M.Y., et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 22 (2007) 1098-1103
30. Dienstag J.L., Goldin R.D., Heathcote E.J., Hann H.W., Woessner M., Stephenson S.L., et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 124 (2003) 105-117
31. Yuen M.F., Cheng C.C., Lauder I.J., Lam S.K., Ooi C.G., and Lai C.L. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 31 (2000) 330-335